Nausea with or without vomiting is very common in early pregnancy, affecting approximately 70% of pregnancies (Maisal 2012). Hyperemesis gravidarum is a severe form of nausea and vomiting in pregnancy that can lead to significant maternal dehydration, electrolyte abnormalities, and weight loss if not properly managed. Pharmacologic treatment is crucial to break the cycle of vomiting, restore oral intake, and prevent complications such as Wernicke’s encephalopathy or hospitalization. Timely and effective treatment improves maternal quality of life, prevents adverse fetal outcomes related to malnutrition, and reduces the need for invasive interventions.
The post Clinical Conundrum: Pregnant and Puking: What’s Safe and Effective in the ED? appeared first on REBEL EM – Emergency Medicine Blog.
Nausea and vomiting in pregnancy (NVP) affects a large percentage of pregnant individuals, ranging from mild symptoms to severe hyperemesis gravidarum (HG). Hyperemesis gravidarum is characterized by intractable vomiting leading to dehydration, electrolyte imbalances, and weight loss, often requiring hospitalization.
When evaluating a pregnant patient with vomiting in the emergency department, it is crucial to rule out other potential causes such as gastroenteritis, pyelonephritis, cholecystitis, appendicitis, diabetic ketoacidosis, migraines, or preeclampsia. Assessment should include evaluating hydration status, electrolyte levels, and checking for ketonuria or significant weight loss. Laboratory tests typically include a comprehensive metabolic panel and urinalysis. Thyroid stimulating hormone (TSH) may be considered if transient gestational thyrotoxicosis is suspected.
Treatment focuses on hydration, correcting electrolyte imbalances, and relieving symptoms. Intravenous isotonic crystalloids, such as normal saline or lactated Ringer’s, are commonly used for rehydration. Thiamine, a B vitamin, is essential for patients with prolonged vomiting, especially before administering dextrose containing fluids, to prevent Wernicke’s encephalopathy. Electrolytes like magnesium or potassium should be repleted as needed.
Pharmacological interventions for NVP and HG typically follow a stepwise approach:
First line therapies often include a combination of vitamin B6 (pyridoxine) and doxylamine, an antihistamine.
Other antiemetic options include:
* Antihistamines such as diphenhydramine, hydroxyzine, or meclizine.
* Phenothiazines like prochlorperazine or promethazine. These can cause sedation and extrapyramidal symptoms. Promethazine should ideally be given deep intramuscularly if administered parenterally due to risk of tissue necrosis with intravenous extravasation.
* Metoclopramide, a dopamine antagonist, which can also cause extrapyramidal symptoms.
* Ondansetron, a serotonin 5-HT3 antagonist, is generally considered safe and effective in pregnancy, with past concerns about birth defects largely refuted or found to be minimal. It is important to monitor for QTc prolongation.
Corticosteroids, such as methylprednisolone or prednisone, are reserved for severe, refractory cases of hyperemesis gravidarum due to potential risks including oral clefts if used in the first trimester, gestational diabetes, and preeclampsia.
Discharge criteria involve improved symptoms, tolerance of oral intake, corrected electrolyte abnormalities, and the ability to manage symptoms at home. Consultation with obstetrics, gastroenterology, or psychiatry may be necessary for complex cases.
https://rebelem.com/clinical-conundrum-pregnant-and-puking-whats-safe-and-effective-in-the-ed/?utm_source=rss&utm_medium=rss&utm_campaign=clinical-conundrum-pregnant-and-puking-whats-safe-and-effective-in-the-ed
